![Jackie Papkoff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jackie Papkoff
Career history of Jackie Papkoff
Former positions of Jackie Papkoff
Companies | Position | Start | End |
---|---|---|---|
California Innovation Center | Corporate Officer/Principal | - | - |
ASSEMBLY BIOSCIENCES, INC. | Corporate Officer/Principal | 2018-04-01 | - |
EVELO BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - | - |
CFD Therapeutics, Inc.
![]() CFD Therapeutics, Inc. Medical SpecialtiesHealth Technology CFD Therapeutics, Inc. (CFD), is being created to develop novel cancer therapeutics stemming from discoveries made previously by diaDexus. CFD will specifically focus on the development of therapeutic monoclonal antibodies directed against proprietary ovarian, pancreatic, breast, colon, prostate and lung cancer targets licensed from diaDexus. diaDexus, Inc. and San Francisco-based Biotechnology Value Fund L.P | Chief Tech/Sci/R&D Officer | 2009-09-16 | - |
Training of Jackie Papkoff
The Salk Institute for Biological Studies | Doctorate Degree |
University of California San Diego | Doctorate Degree |
University of California, Santa Cruz | Undergraduate Degree |
Statistics
International
United States | 8 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 2 |
Sectoral
Consumer Services | 4 |
Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
ASSEMBLY BIOSCIENCES, INC. | Health Technology |
EVELO BIOSCIENCES, INC. | Health Technology |
Private companies | 2 |
---|---|
CFD Therapeutics, Inc.
![]() CFD Therapeutics, Inc. Medical SpecialtiesHealth Technology CFD Therapeutics, Inc. (CFD), is being created to develop novel cancer therapeutics stemming from discoveries made previously by diaDexus. CFD will specifically focus on the development of therapeutic monoclonal antibodies directed against proprietary ovarian, pancreatic, breast, colon, prostate and lung cancer targets licensed from diaDexus. diaDexus, Inc. and San Francisco-based Biotechnology Value Fund L.P | Health Technology |
California Innovation Center |
- Stock Market
- Insiders
- Jackie Papkoff
- Experience